Bio-Rad Laboratories, Inc. Class A Common Stock vs Xcel Energy Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while Xcel Energy Inc trades at $80.51 (market cap $50.24B). The key difference: Xcel Energy Inc is far larger — about 6.3× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Xcel Energy Inc pays a 2.94% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | XEL | |
|---|---|---|
Market Cap | $8.02B | $50.24B |
Sector | Health | Utilities |
52-Week High | $339.75 | $83.91 |
52-Week Low | $241.71 | $68.33 |
Enterprise Value | $7.84B | $87.68B |
Dividend Yield | — | 2.94% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →